Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
| 86.58 BATS BZX Real-Time Price As of 2:20pm ET |  -1.92 / -2.17%Today’s Change | 31.11 Today|||52-Week Range 92.60 | +12.84% Year-to-Date |
Latest ARWR News | Press Releases
No recent news for Arrowhead Pharmaceuticals Inc.
Today’s Trading
| Previous close | 88.50 |
| Today’s open | 88.88 |
| Day’s range | 85.80 - 88.88 |
| Volume | 15,616 |
| Average volume (3 months) | 776,149 |
| Market cap | $9.2B |
Data as of 2:20pm ET, 06/15/2021
Growth & Valuation
| Earnings growth (last year) | -215.92% |
| Earnings growth (this year) | +39.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -47.87% |
| P/E ratio | NM |
| Price/Sales | 49.29 |
| Price/Book | 19.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XLRNAcceleron Pharma Inc | -2.92 | -2.23% |
| FATEFate Therapeutics In... | -3.10 | -3.44% |
| TLRYTilray Inc | -0.94 | -4.91% |
| CRSPCRISPR Therapeutics ... | -5.04 | -3.91% |
Data as of 2:20pm ET, 06/15/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $88.0M |
| Annual profit (last year) | -$84.6M |
| Net profit margin | -96.09% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pasadena, California |
Forecasts
